DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA399194
Title:
Utilization of a NF2-Mutant Mouse Strain to Investigate the Cellular and Molecular Function of the NF2 Tumor Suppressor, Merlin
Descriptive Note:
Annual rept. 15 Sep 2000-14 Sep 2001
Corporate Author:
MASSACHUSETTS GENERAL HOSPITAL BOSTON
Report Date:
2001-10-01
Pagination or Media Count:
18.0
Abstract:
Neurofibromatosis type 2 NF2 is a familial cancer syndrome that features the development of nervous system tumors. The NF2-encoded protein, merlin, localizes to the membranecytoskeleton interface, raising the intriguing question of how a protein that occupies such a physical niche controls cell proliferation. To generate an animal model for NF2 and to build the foundation for delineating the molecular function of merlin, we established a Nf2-mutant mouse strain through genetic engineerins. Nf2- mice develop a spectrum of tumors that is distinct from that of their human counterparts, including osteosarcomas and hepatocellular carcinomas, which exhibit loss of the wild-type Nf2 allele.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE